YOR283W Antibody

What is YOR283W and what organism does it originate from?

YOR283W is a gene that encodes a broad-specificity phosphatase in Saccharomyces cerevisiae (baker's yeast), specifically strain ATCC 204508 / S288c. This phosphatase demonstrates catalytic activity against a diverse range of phosphorylated substrates including nucleoside tri- and diphosphates, phosphorylated organic acids, and amino acids. Interestingly, the enzyme shows selective substrate preferences, displaying no activity against phytic acid, phosphorylated carbohydrates, or nucleoside monophosphates. The protein has a molecular weight of approximately 26,177 Da and functions as a metal-independent phosphatase. YOR283W participates in several essential metabolic pathways including biosynthesis of amino acids, carbon metabolism, and glycolysis/gluconeogenesis, making it a significant target for researchers investigating yeast metabolism and biochemical pathways .

What are the recommended storage conditions for YOR283W antibodies?

YOR283W antibodies should be stored at -20°C or -80°C immediately upon receipt to maintain optimal activity and stability. Researchers should avoid repeated freeze-thaw cycles as these can significantly diminish antibody performance and lead to protein degradation. The antibody is typically supplied in a liquid formulation containing preservatives such as 0.03% Proclin 300 and stabilizers including 50% glycerol in a 0.01M PBS buffer at pH 7.4, which helps maintain antibody integrity during storage. If small volumes of antibody solution become entrapped in the seal of the product vial during shipment or storage, a brief centrifugation on a tabletop centrifuge is recommended to dislodge any liquid in the container's cap. For long-term projects requiring repeated use, aliquoting the antibody into smaller volumes before freezing is advisable to minimize freeze-thaw cycles and preserve antibody function .

What validated applications exist for YOR283W antibody?

YOR283W antibody has been validated for several research applications, with Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) being the primary confirmed methodologies. When using the antibody for Western blotting, researchers should ensure proper identification of the target antigen, which has a molecular weight of approximately 26 kDa. The antibody's polyclonal nature makes it suitable for detecting both native and denatured forms of the protein, offering versatility in experimental design. While not explicitly validated for other applications in the provided data, researchers might explore using this antibody in immunoprecipitation, immunohistochemistry, or immunofluorescence studies following appropriate optimization protocols. When designing experiments, it's crucial to include proper positive and negative controls to verify specificity, particularly when adapting the antibody for novel applications beyond the manufacturer's validated uses .

What is the antibody isotype and host species for YOR283W antibodies?

YOR283W antibodies described in the research literature are polyclonal antibodies of the IgG isotype, raised in rabbits using recombinant Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YOR283W protein as the immunogen. The polyclonal nature of these antibodies means they recognize multiple epitopes on the target protein, potentially increasing detection sensitivity compared to monoclonal alternatives. The rabbit host provides several advantages for research applications, including robust immune responses to a wide range of antigens and production of high-affinity antibodies. Additionally, rabbit IgG antibodies are compatible with most secondary detection systems commonly used in immunological techniques. The antibodies undergo purification via antigen affinity chromatography to enhance specificity and reduce background in experimental applications. This purification method helps eliminate non-specific antibodies from the preparation, resulting in a reagent optimized for detecting the target protein in experimental contexts .

How can one optimize Western blot protocols specifically for YOR283W detection?

Optimizing Western blot protocols for YOR283W detection requires careful consideration of several parameters specific to this phosphatase protein. Begin with sample preparation by extracting yeast proteins under conditions that preserve phosphatase activity—using phosphatase inhibitor-free buffers initially, then comparing results with phosphatase inhibitor-containing buffers to understand the native versus inhibited states. For gel electrophoresis, use 12-15% polyacrylamide gels to achieve optimal resolution around the 26 kDa mark where YOR283W migrates. During transfer, PVDF membranes often provide better results than nitrocellulose for phosphatase detection due to their higher protein binding capacity and chemical resistance. For blocking, a 5% BSA solution in TBST is preferable to milk-based blockers, as milk contains phosphoproteins that may interfere with phosphatase antibody binding. When incubating with primary antibody, optimize by testing dilutions between 1:500 and 1:2000, allowing overnight incubation at 4°C to maximize specific binding while minimizing background .

For signal detection, chemiluminescent systems typically offer the sensitivity required for YOR283W detection, but fluorescent secondary antibodies can provide advantages for quantitative analysis. Following table outlines a systematic approach to optimization:

Include positive controls (recombinant YOR283W protein) and negative controls (lysates from YOR283W knockout yeast strains) to validate specificity and troubleshoot any detection issues .

What experimental design considerations are crucial when studying YOR283W phosphatase activity?

When designing experiments to study YOR283W phosphatase activity, researchers must address several critical considerations to ensure valid and reproducible results. First, substrate selection is paramount—since YOR283W demonstrates broad-specificity phosphatase activity, testing multiple substrates including nucleoside tri- and diphosphates, phosphorylated organic acids, and amino acids will provide comprehensive activity profiling. Simultaneously, negative control substrates such as phytic acid, phosphorylated carbohydrates, and nucleoside monophosphates should be included to confirm selectivity patterns. Second, buffer composition significantly impacts phosphatase activity; researchers should systematically vary pH (5.0-8.0), ionic strength, and divalent cation concentrations to determine optimal catalytic conditions. Third, experimental timing must account for reaction kinetics—conducting time-course experiments from 5 minutes to 2 hours will help establish linearity ranges for accurate determination of enzymatic parameters .

How can the yeast display system be adapted for studying YOR283W antibody specificity and optimization?

The yeast display system presents a powerful platform for studying YOR283W antibody specificity and potentially improving its performance characteristics. To adapt this system, researchers should first clone the YOR283W gene into a yeast surface display vector, ensuring proper fusion with cell wall anchoring domains such as Aga2p. This construct allows for expression of YOR283W protein on the yeast cell surface while maintaining its native conformation. The transformed yeast library can then be screened against the existing YOR283W antibody preparations to assess binding characteristics, or alternatively, new antibody libraries can be screened against the displayed YOR283W protein to identify novel high-affinity binders. Through iterative rounds of selection using fluorescence-activated cell sorting (FACS), researchers can isolate yeast clones displaying antibody variants with improved binding properties, including higher affinity, better specificity, or enhanced stability .

A particularly valuable application involves creating a library of YOR283W mutants displayed on yeast surfaces to map the epitope recognized by the antibody. This approach can identify critical binding regions and inform rational antibody optimization strategies. Quantitative measurements of binding kinetics can be performed directly on the yeast surface using real-time flow cytometry with fluorescently labeled antibodies at varying concentrations. The system also facilitates competitive binding assays to assess cross-reactivity with related phosphatases or other potential off-target interactions. For researchers interested in developing function-blocking antibodies, the yeast display system can be modified to incorporate enzyme activity assays directly on the cell surface, selecting for antibody variants that inhibit phosphatase activity. This powerful combination of display technology with high-throughput screening enables extensive characterization and optimization of YOR283W antibodies that would be prohibitively time-consuming using conventional methods .

What considerations are important when designing knockout or knockdown experiments to validate YOR283W antibody specificity?

Designing rigorous knockout or knockdown experiments to validate YOR283W antibody specificity requires careful attention to several critical factors. First, researchers should employ multiple independent gene disruption techniques to ensure consistent results. For Saccharomyces cerevisiae, this could include CRISPR-Cas9 genome editing for complete gene deletion, RNA interference (if the yeast strain supports it), or promoter replacement with a regulatable promoter for conditional expression. When generating YOR283W knockout strains, researchers should verify disruption at both the genomic level (via PCR and sequencing) and the transcript level (via RT-qPCR), as incomplete disruption can lead to residual protein expression that confounds antibody validation. Importantly, researchers must evaluate the knockout strain's viability and growth characteristics, as deletion of metabolic enzymes can sometimes result in compensatory expression of related proteins .

For antibody validation experiments, paired samples of wild-type and knockout yeast should be processed identically through all experimental procedures. Western blot analysis should be performed with multiple protein loading amounts to assess detection limits and confirm complete absence of the target band in knockout samples. If complete deletion is lethal, researchers can employ degron-tagged versions of YOR283W for inducible protein degradation, allowing temporal control over protein depletion while monitoring antibody signal reduction. Cross-reactivity assessment should include testing the antibody against related phosphatases from the same family to determine specificity boundaries. Additionally, immunoprecipitation followed by mass spectrometry can provide unbiased verification of antibody targets. These comprehensive validation approaches ensure that experimental observations attributed to YOR283W are genuinely related to the target protein and not artifacts of non-specific antibody binding, which is especially important when studying members of protein families with structural similarities .

How can YOR283W antibody be used to investigate protein-protein interactions in metabolic pathways?

YOR283W antibody can serve as a powerful tool for investigating protein-protein interactions within yeast metabolic pathways through several complementary approaches. Co-immunoprecipitation (Co-IP) experiments represent the most direct application, where the YOR283W antibody is used to pull down the phosphatase along with its interacting partners from yeast lysates. These complexes can then be analyzed by mass spectrometry to identify novel interaction partners. For detecting specific suspected interactions, researchers can perform reciprocal Co-IPs using antibodies against potential partner proteins and then probe for YOR283W with its specific antibody. Proximity ligation assays (PLA) offer another powerful approach, where YOR283W antibody is used in conjunction with antibodies against suspected interaction partners to visualize protein complexes in situ, providing spatial information about where in the cell these interactions occur .

For dynamic interaction studies, researchers can combine YOR283W antibody approaches with perturbation experiments, such as carbon source shifts, stress conditions, or cell cycle synchronization, to identify condition-dependent interactions. This can reveal how YOR283W interactions change during metabolic adaptation. Bimolecular Fluorescence Complementation (BiFC) represents another strategy, where potential interaction partners are tagged with complementary fragments of a fluorescent protein, and interaction is confirmed using the antibody for verification via immunoblotting or immunofluorescence. For pathway mapping, sequential chromatin immunoprecipitation (Re-ChIP) can be performed if YOR283W plays any role in transcriptional regulation, first using transcription factor antibodies followed by YOR283W antibody to identify complexes at specific genomic loci. These various applications of YOR283W antibody enable researchers to build comprehensive interaction networks and understand how this phosphatase integrates into broader metabolic regulatory systems in yeast .

What protocols are recommended for studying YOR283W phosphatase activity in different subcellular fractions?

Studying YOR283W phosphatase activity across different subcellular fractions requires careful sample preparation to preserve enzymatic function while achieving clean separation of cellular compartments. Begin with spheroplast preparation using enzymatic digestion (zymolyase treatment) of the yeast cell wall under gentle conditions (30°C, 30 minutes) to prevent premature protein leakage. After spheroplasting, implement differential centrifugation to separate major cellular compartments: low-speed centrifugation (1,000 × g, 10 minutes) for nuclei and cell debris, medium-speed centrifugation (12,000 × g, 15 minutes) for mitochondria and other organelles, and high-speed ultracentrifugation (100,000 × g, 1 hour) to separate microsomes from cytosol. For more refined separation, density gradient centrifugation using sucrose or Percoll gradients can further resolve organelles based on their buoyant densities. Throughout the fractionation process, maintain samples at 4°C and include protease inhibitors to prevent degradation, but importantly, omit phosphatase inhibitors when preparing samples for activity assays .

For each fraction, verify purity by immunoblotting with marker proteins for different compartments (e.g., Pma1 for plasma membrane, Pho8 for vacuole, Pgk1 for cytosol). Phosphatase activity assays should be performed under optimized conditions for YOR283W (typically pH 6.0-7.0) using a panel of substrates including p-nitrophenyl phosphate (pNPP) as a generic substrate and physiologically relevant substrates like ATP, ADP, and phosphorylated metabolic intermediates. The following table presents a systematic approach for analyzing YOR283W activity across subcellular fractions:

Normalize activity measurements to protein concentration in each fraction, and compare activity profiles across fractions to establish the primary subcellular localization of active YOR283W. Additionally, perform Western blotting with the YOR283W antibody on each fraction to correlate protein presence with activity, which can reveal potential post-translational regulation or compartment-specific activation .

How can YOR283W protein turnover be studied using antibody-based approaches?

Studying YOR283W protein turnover using antibody-based approaches can provide valuable insights into the regulation of this phosphatase within yeast cells. Cycloheximide chase assays represent a fundamental approach, where protein synthesis is blocked using cycloheximide, and samples are collected at different time points (0, 1, 2, 4, 8, and 24 hours) for Western blot analysis using YOR283W antibody. The decreasing signal intensity over time reflects the protein's degradation rate, allowing calculation of its half-life. For more sophisticated analysis, pulse-chase experiments combined with immunoprecipitation can be employed, where cells are briefly grown with radioactively labeled amino acids (pulse) followed by growth in non-radioactive media (chase). At various timepoints, YOR283W is immunoprecipitated using its specific antibody, and the decreasing radioactive signal indicates protein turnover rate. To understand degradation mechanisms, researchers can repeat these experiments in strains with impaired proteasome function or autophagy, determining which pathway predominantly contributes to YOR283W degradation .

For in vivo studies of dynamic regulation, the tandem fluorescent protein timer (tFT) approach can be combined with antibody validation. This involves tagging YOR283W with a combination of fast-maturing and slow-maturing fluorescent proteins, creating an age-sensitive fluorescent reporter. The ratio of fluorescent signals correlates with protein age, while parallel antibody detection confirms proper fusion protein expression and localization. To identify specific conditions affecting YOR283W stability, researchers can perform stability profiling across different carbon sources, stress conditions, or cell cycle stages, using the antibody to quantify protein levels while monitoring phosphatase activity. Proteomic approaches using stable isotope labeling (SILAC) followed by immunoprecipitation with YOR283W antibody and mass spectrometry analysis can reveal condition-specific post-translational modifications that might regulate protein stability. These comprehensive approaches to studying YOR283W turnover can reveal important regulatory mechanisms controlling phosphatase activity in response to changing cellular conditions .

What are common sources of false positives or negatives when using YOR283W antibody, and how can they be mitigated?

When working with YOR283W antibody, researchers may encounter several sources of false positives or negatives that can compromise experimental integrity. False positives frequently arise from cross-reactivity with structurally similar phosphatases, particularly those sharing conserved catalytic domains. This issue can be mitigated by performing parallel experiments in YOR283W knockout strains as negative controls and using epitope-tagged YOR283W overexpression systems as positive controls. Non-specific binding to highly abundant proteins is another common source of false positives, especially when using high antibody concentrations. This can be addressed by careful titration of primary antibody concentration and using more stringent washing conditions with increased salt concentration or mild detergents. Post-translational modifications on YOR283W, such as phosphorylation, may affect epitope recognition, leading to condition-dependent false negatives. Researchers should consider using dephosphorylation treatments on a portion of their samples to determine if this affects detection efficiency .

False negatives commonly result from insufficient protein extraction, particularly if YOR283W associates with membrane fractions or forms insoluble complexes under certain conditions. Optimization of extraction buffers with different detergents (CHAPS, NP-40, Triton X-100) can help solubilize the protein effectively. The following troubleshooting approaches are recommended:

For definitive validation, orthogonal detection methods should be employed, such as mass spectrometry verification of immunoprecipitated proteins or correlation of antibody signal with fluorescently tagged YOR283W in microscopy studies. When analyzing data from YOR283W antibody experiments, researchers should always include loading controls, preferably housekeeping proteins of similar abundance to YOR283W, to normalize for sample loading variations .

How can researchers address contradictory findings when comparing YOR283W antibody results across different experimental conditions?

When researchers encounter contradictory findings using YOR283W antibody across different experimental conditions, a systematic troubleshooting and reconciliation approach is essential. First, validate antibody performance under each specific condition by conducting epitope retrieval optimization experiments, as some conditions may mask the epitope or alter protein conformation, affecting antibody recognition. Second, investigate potential post-translational modifications that might occur condition-specifically by performing phosphatase, deglycosylase, or deacetylase treatments on samples prior to antibody detection, as these modifications can significantly impact epitope accessibility. Third, compare multiple antibodies targeting different regions of YOR283W when available, as condition-dependent protein interactions or conformational changes might selectively block certain epitopes while leaving others accessible. Fourth, implement quantitative controls using spiked-in recombinant YOR283W protein to determine if matrix effects from different sample preparations affect antibody sensitivity or specificity .

When contradictions persist despite technical validation, they often reveal meaningful biological phenomena rather than technical artifacts. Researchers should consider several biological explanations: (1) condition-dependent protein localization, where the protein redistributes to different cellular compartments with varying extraction efficiencies; (2) condition-specific protein complexes that mask epitopes or alter antibody accessibility; (3) alternative splicing or proteolytic processing that modifies the protein structure in a condition-dependent manner; or (4) rapid protein turnover under specific conditions leading to apparent abundance changes. To distinguish between these possibilities, complementary approaches such as fluorescent protein tagging for live-cell imaging, RNA analysis for transcriptional changes, and pulse-chase experiments for turnover assessment should be employed. When reporting contradictory findings, researchers should explicitly describe all experimental conditions, including yeast strain background, growth phase, media composition, and sample preparation methods, as these factors significantly influence YOR283W behavior. The integration of these complementary approaches transforms apparent contradictions into valuable insights about context-dependent regulation of YOR283W function .